Trial to use stem cells to treat infant heart defects

The Mayo Clinic has received federal approval for a trial that will use stem cells from babies' own umbilical cords to treat heart defects such as hypoplastic left heart syndrome. The trial, considered the first of its kind, will commence upon enrollment of 10 eligible patients.

View Full Article in:

Star Tribune (Minneapolis-St. Paul, Minn.) · KTTC-TV (Rochester, Minn.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI
Vice President of Finance
Urban Health Plan, Inc.
Bronx, NY
Director of Payor/Provider Contracting
U.S. Medical Management
Tryo, MI